New Data Highlights Abelacimab’s Safety Advantage in Atrial Fibrillation
ACC 2025: Dapagliflozin Found Safe, Effective in Older Adults With Heart Failure Undergoing Valve Replacement
ACC 2025: Ticagrelor Antidote Restores Platelet Function, Treats Bleeding
ACC 2025: Rivaroxaban Comparable to Warfarin in Left Ventricular Blood Clots